Table 1 Patients’ clinical and metabolic parameters at the diagnosis and at the beginning of the therapy.
N (%) | |
|---|---|
Parameters at the diagnosis | |
Age median (inter quartile range) | 54 (47–61) |
Menopausal status | Pre 10 (23.3) |
Post 33 (76.7) | |
Histology | Ductal 36 (83.7) |
Lobular 2 (4.7) | |
Other 5 (11.6) | |
Stage | I-III 25 (58.1) |
IV 18 (41.9) | |
Surgery | No 11 (26.8) |
Yes 30 (73.2) | |
Er (%) | Negative (0) 15 (34.9) |
Positive (≥ 1) 28 (65.1) | |
PgR(%) | Low (≤ 20) 30 (69.8) |
High (> 20) 13 (30.2) | |
Ki67 (%) | Low (≤ 20) 9 (21.9) |
High (> 20) 32 (78.1) | |
Missing 2 | |
Parameters at the beginning of the therapy | |
Age | 58 (52–64) |
Weight median (inter quartile range) | 65 (59–74) |
ECOG performance status | 0 39 (90.7) |
1–2 4 (9.3) | |
BMI | < 25 21 (48.8) |
25–30 16 (37.2) | |
> 30 6 (14.0) | |
Body composition parameters | Median (inter quartile range) |
SM (skeletal muscle; cm2) | 110.18 (97.43–124.58) |
SF (subcutaneous fat; cm2) | 225.06 (150.93–285.02) |
VF (visceral fat; cm2) | 93.77 (44.47–140.79) |
TAFT (Total abdominal fat; cm2) | 299.11 (222.28–399.89) |
SMI (skeletal muscle index; cm2/m2) | 42.26 (36.02–45.04) |
SFI (subcutaneous fat index; cm2/m2) | 82.97 (55.68–118.63) |
VFI (visceral fat index; cm2/m2) | 37.10 (18.04–60.14) |
TAFTI (Total abdominal fat index; cm2/m2) | 118.82 (86.54–157.39) |
